Kamui Pharma Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 7

Kamui Pharma General Information

Description

Developer of a drug discovery platform designed to develop probiotic medicines. The company's drug is used for the treatment of inflammatory bowel disease as it uses long-chain polyphosphoric acid derived from probiotics which helps to cure the diseases, enabling patients to avail of improved treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Care of Asahikawa Medical University
  • 1-1-1 Midorigaoka Higashi 2-jo
  • Asahikawa, 078-8510
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Care of Asahikawa Medical University
  • 1-1-1 Midorigaoka Higashi 2-jo
  • Asahikawa, 078-8510
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kamui Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator Completed Generating Revenue
3. Later Stage VC 01-Jan-2023 Completed Generating Revenue
2. Early Stage VC (Series B) 26-Jul-2022 $4.76M $6.83M Completed Generating Revenue
1. Seed Round 10-May-2018 $2.08M $2.08M Completed Generating Revenue
To view Kamui Pharma’s complete valuation and funding history, request access »

Kamui Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
B preferred
A Preferred
To view Kamui Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Kamui Pharma Patents

Kamui Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026014535-A1 Composition for preventing or treating endometriosis Pending 11-Jul-2024
WO-2026014534-A1 Pharmaceutical composition for preventing or treating interstitial cystitis/bladder pain syndrome Pending 11-Jul-2024
EP-4599833-A1 Pharmaceutical composition containing zinc polyphosphate Pending 27-Oct-2022
US-20260166076-A1 Pharmaceutical composition containing zinc polyphosphate Pending 27-Oct-2022
WO-2024090538-A1 Pharmaceutical composition containing zinc polyphosphate Inactive 27-Oct-2022 A61K33/42
To view Kamui Pharma’s complete patent history, request access »

Kamui Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kamui Pharma Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
CEJ Capital Corporate Venture Capital Minority
Cyberdyne Corporation Minority
DG Ventures Corporate Venture Capital Minority
Angel (individual) Minority
Hokkaido Venture Capital Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Kamui Pharma FAQs

  • When was Kamui Pharma founded?

    Kamui Pharma was founded in 2018.

  • Where is Kamui Pharma headquartered?

    Kamui Pharma is headquartered in Asahikawa, Japan.

  • What is the size of Kamui Pharma?

    Kamui Pharma has 10 total employees.

  • What industry is Kamui Pharma in?

    Kamui Pharma’s primary industry is Drug Discovery.

  • Is Kamui Pharma a private or public company?

    Kamui Pharma is a Private company.

  • What is Kamui Pharma’s current revenue?

    The current revenue for Kamui Pharma is .

  • How much funding has Kamui Pharma raised over time?

    Kamui Pharma has raised $7.17M.

  • Who are Kamui Pharma’s investors?

    CEJ Capital, Cyberdyne, DG Ventures, , and Hokkaido Venture Capital are 5 of 7 investors who have invested in Kamui Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process